Table 1 provides patient characteristics of all reported cases, including the current case. In this study, three cases of ALL and two cases of myeloid neoplasm were collected to explore the differences between APL with FIP1L1::RARA and other hematologic malignancies at the level of transcriptome and lay a certain molecular basis for further research on the treatment and prognosis. This evidence concerns the gene RARA and acute lymphoblastic leukemia.